FULC FINAL DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fulcrum Therapeutics, Inc. Investors to Secure Counsel Before Important June 27 Deadline in Securities Class Action – FULC

NEW YORK, June 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fulcrum Therapeutics Inc. (NASDAQ: FULC) between March 3, 2022 and March 8, 2023, both dates inclusive (the “Class Period”), of the important June 27, 2023 lead plaintiff deadline.

SO WHAT: If you purchased Fulcrum securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Fulcrum class action, go to https://rosenlegal.com/submit-form/?case_id=15766 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 27, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) the preclinical data submitted in support of FTX-6058 (a prospective drug for the potential treatment of sickle-cell disease) showed safety concerns regarding potential hematological malignancies; (2) the foregoing safety concerns increased the likelihood that the U.S. Food and Drug Administration (“FDA”) would place a clinical hold on preclinical studies of FTX-6058; (3) accordingly, Fulcrum had overstated FTX 6058’s clinical and/or commercial prospects; and (4) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Fulcrum class action, go to https://rosenlegal.com/submit-form/?case_id=15766 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8863872

ROSEN, A LEADING NATIONAL FIRM, Encourages UP Fintech Holding Limited Investors to Secure Counsel Before Important Deadline in First Filed Securities Class Action Commenced by the Firm – TIGR

NEW YORK, June 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of UP Fintech Holding Limited (NASDAQ: TIGR) between April 29, 2020 and May 16, 2023, both dates inclusive (the “Class Period”). A class action has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 21, 2023 in the securities class action commenced by the Firm.

SO WHAT: If you purchased UP Fintech securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the UP Fintech class action, go to https://rosenlegal.com/submit-form/?case_id=16262 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 21, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose, among other things, that: (1) UP Fintech’s business was, quite simply, illegal as it related to operations in China as a result of its failure to obtain the proper licenses; (2) it did not fully disclose to investors that it was engaging in unlawful activity and instead characterized the applicable Chinese laws as ambiguous; (3) the foregoing subjected the Company to a heightened risk of regulatory enforcement; and (4); as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the UP Fintech class action, go to https://rosenlegal.com/submit-form/?case_id=16262 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8863799

ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Atlas Lithium Corporation f/k/a Brazil Minerals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – ATLX, BMIX

NEW YORK, June 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Atlas Lithium Corporation f/k/a Brazil Minerals, Inc. (NASDAQ: ATLX, BMIX) between March 25, 2022 and May 3, 2023, both dates inclusive (the “Class Period”), of the important August 1, 2023 lead plaintiff deadline.

SO WHAT: If you purchased Atlas Lithium securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Atlas Lithium class action, go to https://rosenlegal.com/submit-form/?case_id=16825 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 1, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Atlas Lithium overstated the success of its lithium mining and misrepresented the nature of its Brazilian mineral rights; (2) in connection with these misrepresentations, Atlas Lithium conducted deceptive promotions to artificially inflate the value of the Company’s stock; (3) the foregoing conduct was designed to allow its Chief Executive Officer (CEO) and other Company insiders to sell shares back into the market for a profit before the true nature of Atlas Lithium’s business was revealed; and (4) as a result, defendants’ public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Atlas Lithium class action, go to https://rosenlegal.com/submit-form/?case_id=16825 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8863822

Awqaf Minister checks on 48-Arab pilgrims conditions in Mecca

Minister of Awqaf and Islamic Affairs and Holy Sites, Head of Jordanian Hajj missions, Mohammad Khalaileh, on Saturday that the Ministry is responsible for the 48-Arab pilgrims, and that His Majesty King Abdullah’s directives have always been to provide the best services and provide means of comfort for Jordanian and 48-Arab pilgrims. “The ministry’s cadres pay great attention to the 48-Arab pilgrims to perform their Hajj rituals with ease,” Khalaileh said during a visit to residences of 48-Arab pilgrims in the holy city of Mecca on Saturday. He pointed out that the administrative mission is working in full swing to provide 48-Arab pilgrims with all services. For his part, Head of the Higher Coordination Committee for 48-Arab pilgrims, Salim Shalata, expressed appreciation for King Abdullah’s support to the Palestinian cause and people. Shalata commended the significant coordination, cooperation and facilities provided by the Ministry of Awqaf and its cadres to the 48-Arab pilgrims, and lauded the level of services and cooperation of the Ministry mission’s cadres.

Source: Jordan News Agency

13 Jordanian companies participate in Fancy Food Show 2023 New York Sunday

13 major Jordanian companies specialized in the food industry are scheduled to take part Sunday, in Fancy Food Show 2023, which will open in New York City. Jordan Exporters Association (JEA) will participate in the three-day event, while the participating local industrial companies are specialized in the sectors of Arabic desserts, spices, thyme, nuts and coffee. In a statement on Saturday, JEA general director, Halim Abu Rahma, said Jordan’s participation represents an opportunity to get acquainted with new trading partners globally and open new and promising markets, especially those with which Jordan has free trade agreements. Abu Rahma noted the exhibition constitutes the largest event specialized in food and beverages in North America, and attracts exhibitors and visitors from all over the world. JEA has been participating in the exhibition since 2013, as part of its plans and programs to support and enable the industry to enter new markets, he said. Abu Rahma called on companies to optimize benefit from participating in the food show by networking and promoting Jordanian industry, seeking to conclude deals and attract buyers. Stressing importance of supporting participation in foreign exhibitions, he said this policy is a “successful” way to promote exports and open new markets, to achieve goals of the executive program of Economic Modernization Vision (EMV) in increasing national exports during the next three years to more than JD9 billion. Abu Rahma noted U.S. is one of the strongest markets, in terms of purchasing power and a promising destination for national exports, as multiple national products could U.S. market and meet its needs, due to existence of a free trade agreement (FTA) signed between the two countries. Jordan signed a FTA with U.S. in 2000, aimed to strengthening friendship and economic, trade and investment cooperation. During the first quarter of 2023, national exports to the U.S. increased by 8% to reach JD394 million, compared to JD365 million for the same period last year, according to official data.

Source: Jordan News Agency

National Rehabilitation Centre: Prominent role in preventing drug addiction and protecting society from its dangers

ABU DHABI, 24th June, 2023 (WAM) The UAE is joining the international community in celebrating the International Day Against Drug Abuse and Illicit Trafficking under the theme “People first: stop stigma and discrimination, strengthen prevention. The Day sheds light on the global crisis that communities face as a result of the abuse of psychotropic substances, and to raise awareness of its dangers and negative impact on the individuals and societies as a whole. The International Day against Drug Abuse and Illicit Trafficking is marked on 26th June every year, to strengthen action and cooperation in achieving the goal of a world free of drug abuse. And each year, individuals, entire communities, and various organizations all over the world join in on this global observance, to raise awareness of the major problem that illicit drugs represent for society. The aim of this year’s campaign is to raise awareness about the importance of treating people who use drugs with respect and empathy; providing evidence-based, voluntary services for all; offering alternatives to punishment; prioritizing prevention; and leading with compassion. The campaign also aims to combat stigma and discrimination against people who use drugs by promoting language and attitudes that are respectful and non-judgmental. In the following report, the Emirates News Agency (WAM) reviews the UAE’s efforts in general and the National Rehabilitation Centre (NRC) in particular in the field of drug control and raising awareness of its dangers. The UAE’s efforts in combating drugs are in accordance with a comprehensive strategy that takes into account this issue, which poses a serious threat to countries all over the world. The UAE has worked continuously to update laws and legislations related to drug control, in addition to security, preventive, curative and awareness efforts. NRC’s efforts in combating addiction and psychotropic substances and raising awareness of their dangers have reached very advanced levels, comparable to the most prestigious international institutions. Since its establishment, the NRC has contributed to raising societal awareness on the dangers of addiction through innovative programmes and plans in facing it, in conjunction with the development of medical treatment services, studies and scientific research which would contribute to achieving its operational objectives. In 2022 and the first quarter of 2023, the centre achieved a number of prime accomplishments including increasing the capacity of the centre from 78 beds to 90 beds by the end of 2022 to 114 beds by the end of the first quarter of 2023. It also improved and developed the channels for requesting the centre’s services through the TAMM and its website, in addition to the smart application and telephone communication. The Treatment procedures and programmes have also been reviewed and upscaled to enhance patient’s experience and treatment outcomes, and to increase the number of outpatient clinics to accommodate the largest number of patients and reducing waiting lists. The centre is equipped with the-stat-of-the-art technology techniques that assist in the treatment of addiction, such as the use of smart phones, applications and Internet programmes. In the centre, technology was utilised to create support groups via videoconferencing to provide documented technical resources for patients and their families, in addition to follow-ups for patients through some advanced programmes that help in following up patients remotely while they are at their homes. A new programme is being developed for the first time, which will be used to monitor and follow-up addiction patients remotely. This programme will also enable the medical team to communicate with the patient, follow up on his vital signs while at home, and provide immediate medical advice. The centre is working on creating a number of treatment programmes and presenting them to patients, where a specialised clinic for teenagers has been created, the (Adolescent Outpatient Programme), which is a dynamic, specialised service that seeks to involve young people between 15 and 18 years old, who suffer from substance use disorder (SUD), through which a comprehensive multidisciplinary assessment that fit their needs through evidence-based medical and psychological interventions. A specialised gym has also been established for patients, which contributes to the rehabilitation process and serves patients even after discharging from the centre. A building for visitors has also been established to preserve patients’ privacy during entry and exit from the centre. At the same time, it provides a suitable place for family visits, in addition to reducing the number of waiting days for a maximum of 14 days. The intake and assessment of patient with addiction problems is a comprehensive and collaborative process between the patient and the NRC clinical team, headed by the psychiatrist. Each one of the clinical team meets with the patient and do his/her assessment and by the end of the intakeassessment process the team members convene to decide the most suitable treatment plan for the patient and then allocate the patient to the appropriate services according to assessed needs and identify and do referral to other services if needed, for example referral to the ER in case of medical emergency. The purpose of the assessment is to establish therapeutic relationship with the client; obtain full history regarding drug and alcohol use problems, other comorbid psychiatric or medical problems, social/family problems, legal and financial problems and formulate a multidisciplinary treatment plan for the patient, who remains under observation at outpatient’s clinic for at least four months and some patients need years for treatment. The addiction treatment aims to help patients get rid of substances from their bodies in a safe manner and overcome the side effects which may accompany this phase, help patients to abstain from using drugs and work as hard as possible in order not to revert back to using once more, help patients to return back to their normal lives and avoid complication which may result from using substances such as contracting some serious diseases, accidents or death. The NRC applies other methods in its treatment like real patient’s success stories, the vocational programme which aims to train patients on computer skills and applications which shall help them attain a useful qualification which help them market themselves in labour market or develop their private business and digitalising them and the recreating programme aims to include inpatients in the general, religious and seasonal celebrations such as end of Ramadan celebration, Eid Al Adha, Martyr Day, National Day, Mid-Sha’aban, haq Laila and Ramadhan evening celebrations .. The NRC has many facilities including a library, gym, Majlis and outside garden. The NRC has received a prestigious certification from the United Nations. The World Health Organisation (WHO) has appointed NRC as a collaborative centre in the field of “prevention and treatment of disorders resulting from the use of psychotropic substances”, making it the first addiction treatment centre in the UAE to receive this designation in the Middle East. This recognition strengthened NRC’s status as a leading centre in the prevention, treatment and rehabilitation from addiction at regional and global levels. The NRC has achieved a scientific achievement for the second time in a row, the first of its kind and unprecedented in the Middle East, Africa and the Gulf region, by obtaining an accredited certification from the United Nations Office on Drugs and Crime (UNODC) in Vienna as a “Participant and Collaborative Centre”. The Centre was awarded the certificate as a Participant and Collaborative Centre with the United Nations Office, for the second time in a row, in the discovery and analysis of traditional, manufactured and modern narcotics drugs, proving its excellence in developing accurate and sensitive methods to identify chemical changes in modern drugs composition, after fulfilling all the requirements for participation in the ‘Drug and Substance Use Testing Laboratories’ programme. Dr. Aref Al Shehhi, CEO of NRC, said: “This outstanding achievement solidifies the UAE’s prominent status and puts the emirate of Abu Dhabi at the forefront of Middle East. This accomplishment would not have been possible without the support of our wise leadership and their guidance that enable us to compete regionally and globally.” He added: “NRC’s efforts in combating addiction and psychotropic substances have contributed to raising community awareness of the dangers of drugs and have reached advanced levels comparable to the most prestigious international institutions, through innovative programmes and plans designed to address this pressing issue. Such efforts are made in conjunction with the development of treatment services, studies and scientific research that will achieve the Centre’s operational objectives.” “NRC has always demonstrated its regional status as a leading centre in the delivery of addiction prevention, treatment and rehabilitation services. Furthermore, the Centre has set new benchmarks in providing treatment, rehabilitation and training services through adopting effective and scientifically proven methods in the treatment of addiction.” The NRC has conducted a series of research and studies to understand and to effectively respond to addiction and to develop research-based monitoring and evaluation (surveillance programmes). As a centre of excellence that collaborates with the World Health Organisation (WHO) in the field of substance abuse in the middle East, the NRC has joined the International Technology Transfer Centre (ITTC) network, making it the only entity from the region to become part of this network. The network aims to develop the skills of professionals, organisations and systems that provide substance use prevention, treatment, rehabilitation, and recovery support services. The ITTC Network will contribute to implementing the modules included in the training programmes not just in the UAE, but also in the wider region. The centre established a partnership with the Colombo Plan with the view of enhancing its position and role as an international centre of excellence in all areas related to decreasing drug and alcohol demand. The agreement aims to establish a journal which specializes in substance use disorders (International Journal of Prevention and Treatment of Substance Use Disorders), deliver various training courses to a variety of organisations in the UAE, and conduct awareness campaigns and publish information through the internet, audio-visual media and social platforms.

Source: Emirates News Agency (WAM)